2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
80
Head and Neck Neoplasms
72
Nasopharyngeal Carcinoma
61
Prostatic Neoplasms
51
Oropharyngeal Neoplasms
30
Carcinoma, Non-Small-Cell Lung
27
Rectal Neoplasms
23
Carcinoma, Squamous Cell
23
Breast Neoplasms
23
Glioblastoma
22
Uterine Cervical Neoplasms
18
Carcinoma
18
Neoplasm Metastasis
16
Brain Neoplasms
16
Nasopharyngeal Neoplasms
15
Pancreatic Neoplasms
14
Lung Neoplasms
13
Gliosarcoma
13
Glioma
13
Esophageal Neoplasms
13
Radiation Injuries
12
Mouth Neoplasms
12
Laryngeal Neoplasms
12
Esophageal Squamous Cell Carcinoma
12
Astrocytoma
12
Tongue Neoplasms
11
Hypopharyngeal Neoplasms
11
Sarcoma
10
Neoplasms
10
Salivary Gland Neoplasms
8
Interventions
human papillomavirus vaccine, L1 type 16, 18
3
Oncolytic Virotherapy
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Bevacizumab
2
valrubicin
1
thymoglobulin
1
ledipasvir, sofosbuvir drug combination
1
hepatitis C immune globulin, human
1
halofantrine
1
VP-102
1
Therapies, Investigational
1
Tenofovir
1
Rituximab
1
Radiotherapy, Intensity-Modulated
1
Papillomavirus Vaccines
1
Nimorazole
1
Mitomycin
1
Lamivudine
1
Kidney Transplantation
1
Ipilimumab
1
Interferons
1
Influenza Vaccines
1
Immunoglobulin G
1
Imiquimod
1
Gemcitabine
1
Gels
1
Fluorescent Antibody Technique
1
Drug Therapy
1
Cyclophosphamide
1
Cisplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Virus Diseases
×
Radiotherapy, Intensity-Modulated
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled